Format

Send to

Choose Destination
Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):3064-3073. doi: 10.1167/iovs.18-25999.

Hybrid Compound SA-2 is Neuroprotective in Animal Models of Retinal Ganglion Cell Death.

Author information

1
Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, United States.
2
North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, Texas, United States.
3
Department of Pharmaceutical Sciences, University of North Texas Health Science Center, Fort Worth, Texas, United States.
4
Department of Bioengineering, The University of Texas at Arlington, Arlington, Texas, United States.

Abstract

Purpose:

Determine the toxicity, bioavailability in the retina, and neuroprotective effects of a hybrid antioxidant-nitric oxide donor compound SA-2 against oxidative stress-induced retinal ganglion cell (RGC) death in neurodegenerative animal models.

Methods:

Optic nerve crush (ONC) and ischemia reperfusion (I/R) injury models were used in 12-week-old C57BL/6J mice to mimic conditions of glaucomatous neurodegeneration. Mice were treated intravitreally with either vehicle or SA-2. Retinal thickness was measured by spectral-domain optical coherence tomography (SD-OCT). The electroretinogram and pattern ERG (PERG) were used to assess retinal function. RGC survival was determined by counting RBPMS-positive RGCs and immunohistochemical analysis of superoxide dismutase 1 (SOD1) levels was carried out in the retina sections. Concentrations of SA-2 in the retina and choroid were determined using HPLC and MS. In addition, the direct effect of SA-2 treatment on RGC survival was assessed in ex vivo rat retinal explants under hypoxic (0.5% O2) conditions.

Results:

Compound SA-2 did not induce any appreciable change in retinal thickness, or in a- or b-wave amplitude in naive animals. SA-2 was found to be bioavailable in both the retina and choroid after a single intravitreal injection (2% wt/vol). An increase in SOD1 levels in the retina of mice subjected to ONC and SA-2 treatment, suggests an enhancement in antioxidant activity. SA-2 provided significant (P < 0.05) RGC protection in all three of the tested RGC injury models in rodents. PERG amplitudes were significantly higher in both I/R and ONC mouse eyes following SA-2 treatment (P ≤ 0.001) in comparison with the vehicle and control groups.

Conclusions:

Compound SA-2 was effective in preventing RGC death and loss of function in three different rodent models of acute RGC injury: ONC, I/R, and hypoxia.

PMID:
31348824
DOI:
10.1167/iovs.18-25999

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center